Dougherty Wealth Advisers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Dougherty Wealth Advisers’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400	Closed	-$14.2K	–	133
2023 Q1	$14.2K	Hold	400	–	–	0.02%	115
2022 Q4	$14.7K	Hold	400	–	–	0.02%	116
2022 Q3	$19K	Hold	400	–	–	0.04%	110
2022 Q2	$29K	Hold	400	–	–	0.05%	99
2022 Q1	$32K	Hold	400	–	–	0.05%	104
2021 Q4	$41K	Hold	400	–	–	0.06%	106
2021 Q3	$35K	Hold	400	–	–	0.05%	110
2021 Q2	$36K	Hold	400	–	–	0.05%	107
2021 Q1	$30K	Hold	400	–	–	0.05%	110
2020 Q4	$27K	Hold	400	–	–	0.04%	122
2020 Q3	$21K	Hold	400	–	–	0.07%	130
2020 Q2	$23K	Hold	400	–	–	0.08%	133
2020 Q1	$16K	Hold	400	–	–	0.06%	144
2019 Q4	$24K	Hold	400	–	–	0.07%	146
2019 Q3	$21K	Hold	400	–	–	0.07%	149
2019 Q2	$20K	Hold	400	–	–	0.06%	174
2019 Q1	$21K	Hold	400	–	–	0.07%	152
2018 Q4	$20K	Buy	+400	New	+$18.6K	0.07%	158

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dougherty Wealth Advisers's SYNH Position: Q2 2023 in Review

Dougherty Wealth Advisers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 400 shares — an estimated $14.2K sold.

Dougherty Wealth Advisers first reported a position in SYNH in Q4 2018 and held it in 18 quarters. The position peaked at $41K in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Dougherty Wealth Advisers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Dougherty Wealth Advisers sold 400 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $14.2K.
Dougherty Wealth Advisers first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 18 quarters.
Dougherty Wealth Advisers's Syneos Health, Inc. Class A Common Stock position peaked at $41K in Q4 2021.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Dougherty Wealth Advisers's 13F filing for Q2 2023, filed 3 Aug 2023.